prospective cohort study of COVID-19 antibody for medical stuff in hospital

prospective cohort study of COVID-19/SARS-nCoV2 antibody for both medical doctors and dentists in Gunma Prefectural Cancer Center. - Prospective SARS-nCov2 antibody study in GCC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040679

Enrollment

Registered

2020-06-09

Start date

2020-06-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19/SARS-nCoV2

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: physician and dentists in GCC

Exclusion criteria

Exclusion criteria: other than physician and dentists in GCC

Design outcomes

Primary

Measure	Time frame
evaluation of changes of antibodies of SARS-nCoV2 in medical stuff.	—

Countries

Japan

Contacts

Public ContactKazuhiro Araki

Gunma prefectural cancer center medical oncology

kaz-araki@gunma-cc.jp0276380771

Outcome results